Paget disease of the nipple

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180275C50.0
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Paget disease of the nipple, also known as mammary Paget disease or Paget disease of the breast, is a rare form of breast cancer that manifests as eczema-like changes of the nipple and areola. It accounts for approximately 1–3% of all breast cancers and is most commonly diagnosed in postmenopausal women, though it can occur at any age in adulthood. The condition is characterized by the presence of malignant Paget cells (large, pale-staining adenocarcinoma cells) within the epidermis of the nipple. Key symptoms include persistent redness, scaling, crusting, and flaking of the nipple skin, often accompanied by itching, burning, or tingling sensations. Patients may also experience nipple discharge (which can be bloody or serous), nipple retraction, or ulceration. Because these symptoms can mimic benign dermatological conditions such as eczema or dermatitis, diagnosis is frequently delayed. In the majority of cases (approximately 80–90%), Paget disease of the nipple is associated with an underlying breast carcinoma, either ductal carcinoma in situ (DCIS) or invasive breast cancer. A palpable breast mass may or may not be present. Diagnosis is confirmed through biopsy of the affected nipple skin, which reveals the characteristic Paget cells. Imaging studies such as mammography, ultrasound, and MRI are used to evaluate for underlying breast malignancy. Treatment depends on the extent of disease and typically involves surgical intervention, ranging from mastectomy to breast-conserving surgery (central lumpectomy with removal of the nipple-areola complex), often combined with radiation therapy. Sentinel lymph node biopsy is performed when invasive disease is suspected. Adjuvant systemic therapies, including chemotherapy, hormonal therapy, and HER2-targeted therapy, may be recommended based on the characteristics of any associated underlying breast cancer. Prognosis is generally favorable when the disease is confined to the nipple without an underlying invasive carcinoma, but outcomes depend significantly on the stage and biology of any associated breast cancer.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Paget disease of the nipple.

View clinical trials →

No actively recruiting trials found for Paget disease of the nipple at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Paget disease of the nipple community →

Specialists

1 foundView all specialists →
AG
Ayca Gucalp
NEW YORK, NY
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Paget disease of the nipple.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Paget disease of the nippleForum →

No community posts yet. Be the first to share your experience with Paget disease of the nipple.

Start the conversation →

Latest news about Paget disease of the nipple

No recent news articles for Paget disease of the nipple.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Paget disease of the nipple

What is Paget disease of the nipple?

Paget disease of the nipple, also known as mammary Paget disease or Paget disease of the breast, is a rare form of breast cancer that manifests as eczema-like changes of the nipple and areola. It accounts for approximately 1–3% of all breast cancers and is most commonly diagnosed in postmenopausal women, though it can occur at any age in adulthood. The condition is characterized by the presence of malignant Paget cells (large, pale-staining adenocarcinoma cells) within the epidermis of the nipple. Key symptoms include persistent redness, scaling, crusting, and flaking of the nipple skin, ofte

How is Paget disease of the nipple inherited?

Paget disease of the nipple follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Paget disease of the nipple typically begin?

Typical onset of Paget disease of the nipple is adult. Age of onset can vary across affected individuals.

Which specialists treat Paget disease of the nipple?

1 specialists and care centers treating Paget disease of the nipple are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.